DE69803303D1 - Verwendung von endipalen zur behandlung von schuppenflechte - Google Patents

Verwendung von endipalen zur behandlung von schuppenflechte

Info

Publication number
DE69803303D1
DE69803303D1 DE69803303T DE69803303T DE69803303D1 DE 69803303 D1 DE69803303 D1 DE 69803303D1 DE 69803303 T DE69803303 T DE 69803303T DE 69803303 T DE69803303 T DE 69803303T DE 69803303 D1 DE69803303 D1 DE 69803303D1
Authority
DE
Germany
Prior art keywords
treat psoriasis
endipales
lonapalene
seems
side effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69803303T
Other languages
English (en)
Other versions
DE69803303T2 (de
Inventor
Giorgio Endrici
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69803303D1 publication Critical patent/DE69803303D1/de
Application granted granted Critical
Publication of DE69803303T2 publication Critical patent/DE69803303T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
DE69803303T 1997-08-29 1998-08-27 Verwendung von endipalen zur behandlung von schuppenflechte Expired - Fee Related DE69803303T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1997TN000008A IT1304595B1 (it) 1997-08-29 1997-08-29 Inibitore della 5-lipoossigenasi
PCT/IT1998/000236 WO1999011249A2 (en) 1997-08-29 1998-08-27 Use of endipalene in the treatment of psoriasis

Publications (2)

Publication Number Publication Date
DE69803303D1 true DE69803303D1 (de) 2002-02-21
DE69803303T2 DE69803303T2 (de) 2002-05-02

Family

ID=11408676

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69803303T Expired - Fee Related DE69803303T2 (de) 1997-08-29 1998-08-27 Verwendung von endipalen zur behandlung von schuppenflechte

Country Status (15)

Country Link
US (1) US6291534B1 (de)
EP (1) EP1011649B1 (de)
JP (1) JP2001514214A (de)
CN (1) CN1268887A (de)
AT (1) ATE209033T1 (de)
AU (1) AU9183698A (de)
BR (1) BR9811402A (de)
CA (1) CA2302241A1 (de)
DE (1) DE69803303T2 (de)
DK (1) DK1011649T3 (de)
ES (1) ES2165701T3 (de)
HK (1) HK1029058A1 (de)
IT (1) IT1304595B1 (de)
PT (1) PT1011649E (de)
WO (1) WO1999011249A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010154A1 (en) * 1991-11-12 1993-05-27 Protein Polymer Technologies, Inc. High molecular weight collagen-like protein polymers
EP2123265B1 (de) * 2008-05-23 2012-05-23 NOVAERA S.r.l. Endipalenformulierungen bei der Behandlung von Psoriasis
AU2010241567B2 (en) 2009-04-29 2013-10-31 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732964B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux amides tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
US6156790A (en) * 1997-12-30 2000-12-05 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities

Also Published As

Publication number Publication date
IT1304595B1 (it) 2001-03-19
DK1011649T3 (da) 2002-05-21
EP1011649A2 (de) 2000-06-28
US6291534B1 (en) 2001-09-18
EP1011649B1 (de) 2001-11-21
WO1999011249A2 (en) 1999-03-11
AU9183698A (en) 1999-03-22
WO1999011249A3 (en) 1999-09-16
BR9811402A (pt) 2000-08-29
CA2302241A1 (en) 1999-03-11
ES2165701T3 (es) 2002-03-16
DE69803303T2 (de) 2002-05-02
CN1268887A (zh) 2000-10-04
ITTN970008A1 (it) 1999-03-01
HK1029058A1 (en) 2001-03-23
ATE209033T1 (de) 2001-12-15
PT1011649E (pt) 2002-05-31
JP2001514214A (ja) 2001-09-11

Similar Documents

Publication Publication Date Title
ATE380548T1 (de) Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE126441T1 (de) Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen.
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
ATE247987T1 (de) Behandlung zur beseitigung von gerüchen
ATE371457T1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE69926385D1 (de) Behandlung von geweben
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE69738045D1 (de) Verwendung von cetrorelix zur behandlung von benigne prostatahypertrophie und prostatakrebs
ATE249220T1 (de) Verwendung von piperin und derivate davon zur behandlung von hautpigmentierungstörungen und hautkrebs
NO994330L (no) Metode for behandling av en tumor
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE69803303D1 (de) Verwendung von endipalen zur behandlung von schuppenflechte
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69518438D1 (de) Behandlung von übereregten nervenzellenfunktionen
ATE238796T1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
DE69924979D1 (de) Behandlung von chronischen schmerzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee